Yoshihide Sunada

J-GLOBAL         Last updated: Nov 12, 2018 at 11:43
 
Avatar
Name
Yoshihide Sunada
Affiliation
Kawasaki Medical School
Section
School of Medicine
Job title
Professor

Research Areas

 
 
  • Clinical internal medicine / Neurology / 

Awards & Honors

 
2013
Poster Award, the XXI World Congress of Neurology
 

Misc

 
Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, Takeshima H, Ma J.
The Journal of biological chemistry   284(23) 15894-15902   Jun 2009
Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Mukai H, Katsumata N, Sunada Y, Watanabe T, Hausheer FH.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   -(-) -   Mar 2009
Inoue K, Hemmi S, Miyaishi M, Kutoku Y, Murakami T, Kurokawa K, Sunada Y.
European journal of neurology : the official journal of the European Federation of Neurological Societies   16 76-80   Jan 2009
Caveolin-3 regulates myostatin signaling. Mini-review
Ohsawa Y, Okada T, Kuga A, Hayashi S, Murakami T, Tsuchida K, Noji S, Sunada Y.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases   27 19-24   Nov 2008
Hemmi S, Kutoku Y, Inoue K, Murakami T, Sunada Y.
Muscle & nerve   38(4) 1341-3   Oct 2008

Books etc

 
特集 研修医のための身体所見のとり方「麻痺と四股のしびれ」. 診断と治療
診断と診療社   
200500

Conference Activities & Talks

 
Introduction of wound-healing MRL-MpJ phenotype improves skeletal muscle pathology in mdx mouse.
14th International Congress of The World Muscle Society   2009   
Muscle mass regulation by myostatin-signaling related molecules
8th French-Japanese Workshop on Muscular Dystrophies   2009   
A small-molecule inhibitor targeting transforming growth factor-b type Ⅰ receptor kinase ameliorate muscular atrophy in a mouse model of caveolin-3-deficient muscular dystrophy.
13th International Congress of World Muscle Society   2008   
Myostatin inhibition increases atrogin-1 expression and accelerates skeletal muscle atrophy under denervated conditions.
12th WMS International Cogress   2007   
Therapeutic effects of small-molecule inhibitors of type I TGF-b receptors for the treatment of muscular dystrophy.
FASEB Summer research Conferences, "TGF-βSuperfamily: Signaling & Development"   2007